What is he best known for?
The fields of study he is best known for:
- Internal medicine
- Heart failure
- Cardiology
His primary areas of study are Internal medicine, Cardiology, Heart failure, Natriuretic peptide and Intensive care medicine.
His Internal medicine research includes themes of Endocrinology and Surgery.
In his research, Cohort is intimately related to Blood pressure, which falls under the overarching field of Cardiology.
His work carried out in the field of Heart failure brings together such families of science as Biomarker, Odds ratio, Proportional hazards model and Hazard ratio.
The concepts of his Natriuretic peptide study are interwoven with issues in Area under the curve, Framingham Risk Score, Clinical endpoint, GDF15 and Systole.
The Intensive care medicine study combines topics in areas such as Meta-analysis, Adverse effect, Anemia and Clinical trial.
His most cited work include:
- 2013 ACCF/AHA Guideline for the Management of Heart Failure: A Report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines (9721 citations)
- 2013 ACCF/AHA Guideline for the Management of Heart Failure: Executive Summary A Report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines (2430 citations)
- The N-terminal Pro-BNP investigation of dyspnea in the emergency department (PRIDE) study. (949 citations)
What are the main themes of his work throughout his whole career to date?
James L. Januzzi mainly investigates Internal medicine, Cardiology, Heart failure, Natriuretic peptide and Ejection fraction.
His research ties Endocrinology and Internal medicine together.
His research in Cardiology intersects with topics in Prospective cohort study and Renal function.
His work carried out in the field of Heart failure brings together such families of science as Hazard ratio, Emergency department, Clinical trial and Intensive care medicine.
His Natriuretic peptide research incorporates elements of Heart disease and Confidence interval.
His Ejection fraction research is multidisciplinary, relying on both Valsartan and Ventricular remodeling.
He most often published in these fields:
- Internal medicine (72.40%)
- Cardiology (57.47%)
- Heart failure (50.90%)
What were the highlights of his more recent work (between 2019-2021)?
- Internal medicine (72.40%)
- Heart failure (50.90%)
- Cardiology (57.47%)
In recent papers he was focusing on the following fields of study:
The scientist’s investigation covers issues in Internal medicine, Heart failure, Cardiology, Ejection fraction and Natriuretic peptide.
He combines Internal medicine and In patient in his studies.
The study incorporates disciplines such as Valsartan, Clinical trial, Randomized controlled trial and Intensive care medicine in addition to Heart failure.
His research integrates issues of Diabetes mellitus and MEDLINE in his study of Cardiology.
Comorbidity is closely connected to Atrial fibrillation in his research, which is encompassed under the umbrella topic of Ejection fraction.
The Natriuretic peptide study combines topics in areas such as Emergency department and Renal function.
Between 2019 and 2021, his most popular works were:
- Cardiovascular and Renal Outcomes with Empagliflozin in Heart Failure (373 citations)
- Prevalence and Impact of Myocardial Injury in Patients Hospitalized With COVID-19 Infection. (183 citations)
- Fewer Hospitalizations for Acute Cardiovascular Conditions During the COVID-19 Pandemic. (80 citations)
In his most recent research, the most cited papers focused on:
- Internal medicine
- Disease
- Myocardial infarction
His scientific interests lie mostly in Heart failure, Internal medicine, Cardiology, Ejection fraction and Myocardial infarction.
James L. Januzzi works on Heart failure which deals in particular with Natriuretic peptide.
His Internal medicine study combines topics in areas such as Diabetes mellitus and MEDLINE.
James L. Januzzi has included themes like Shock and Adverse outcomes in his Cardiology study.
His Ejection fraction study integrates concerns from other disciplines, such as Blood pressure, Orthostatic vital signs, Beta blocker, Asymptomatic and Loop diuretic.
His studies deal with areas such as Young adult, Myocarditis and Risk factor as well as Myocardial infarction.
This overview was generated by a machine learning system which analysed the scientist’s
body of work. If you have any feedback, you can
contact us
here.
